• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型盐皮质激素拮抗剂美螺内酯对醛固酮诱导的高血压的作用

Effect of a new mineralocorticoid antagonist mespirenone on aldosterone-induced hypertension.

作者信息

Opoku J, Kalimi M, Agarwal M, Qureshi D

机构信息

Department of Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.

出版信息

Am J Physiol. 1991 Feb;260(2 Pt 1):E269-71. doi: 10.1152/ajpendo.1991.260.2.E269.

DOI:10.1152/ajpendo.1991.260.2.E269
PMID:1996630
Abstract

The effects of the mineralocorticoid antagonist mespirenone on the development and maintenance of aldosterone-induced hypertension in Sprague-Dawley rats has been studied. Uninephrectomized saline-drinking male Sprague-Dawley rats were injected with either 0.2 ml olive oil, 50 g aldosterone, 1 mg mespirenone, 50 g aldosterone plus 500 g mespirenone, or 50 g aldosterone plus 1 mg mespirenone, each dissolved in 0.2 ml olive oil. Administration of aldosterone alone significantly increased the systolic blood pressure (SBP) from a control value of 114 +/- 3.6 to 162 +/- 4 mmHg by the end of the 3-wk experimental period. Mespirenone given alone had no effect on SBP. However, mespirenone given in combination with aldosterone reversed the hypertension caused by aldosterone in a dose-dependent manner. Saline consumption and urinary output were slightly increased in aldosterone-treated rats compared with the other groups, but the body and organ weights were comparable in all groups. Microscopic examination of kidney and heart showed no abnormalities due to mespirenone. These results suggest that in vivo administration of mespirenone to Sprague-Dawley rats effectively prevents the aldosterone-induced hypertension.

摘要

研究了盐皮质激素拮抗剂美螺内酯对Sprague-Dawley大鼠醛固酮诱导的高血压发展和维持的影响。将单侧肾切除并饮用生理盐水的雄性Sprague-Dawley大鼠分别注射0.2 ml橄榄油、50 μg醛固酮、1 mg美螺内酯、50 μg醛固酮加500 μg美螺内酯或50 μg醛固酮加1 mg美螺内酯,每种均溶于0.2 ml橄榄油中。单独给予醛固酮在3周实验期结束时可使收缩压(SBP)从对照值114±3.6显著升高至162±4 mmHg。单独给予美螺内酯对SBP无影响。然而,美螺内酯与醛固酮联合使用可剂量依赖性地逆转醛固酮引起的高血压。与其他组相比,醛固酮处理的大鼠的盐水消耗量和尿量略有增加,但所有组的体重和器官重量相当。对肾脏和心脏的显微镜检查未发现美螺内酯导致的异常。这些结果表明,对Sprague-Dawley大鼠体内给予美螺内酯可有效预防醛固酮诱导的高血压。

相似文献

1
Effect of a new mineralocorticoid antagonist mespirenone on aldosterone-induced hypertension.新型盐皮质激素拮抗剂美螺内酯对醛固酮诱导的高血压的作用
Am J Physiol. 1991 Feb;260(2 Pt 1):E269-71. doi: 10.1152/ajpendo.1991.260.2.E269.
2
Effects of antimineralocorticoid RU 26752 on steroid-induced hypertension in rats.
Am J Physiol. 1990 May;258(5 Pt 1):E737-9. doi: 10.1152/ajpendo.1990.258.5.E737.
3
Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension.脑室内注入RU28318可阻断醛固酮-盐性高血压。
Am J Physiol. 1990 Mar;258(3 Pt 1):E482-4. doi: 10.1152/ajpendo.1990.258.3.E482.
4
Experimental studies on the endocrine side effects of new aldosterone antagonists.
Arzneimittelforschung. 1988 Dec;38(12):1800-5.
5
Inhibitory effects of the novel anti-aldosterone compound mespirenone on adrenocortical steroidogenesis in vitro.新型抗醛固酮化合物美螺内酯对体外肾上腺皮质类固醇生成的抑制作用。
Arzneimittelforschung. 1991 Sep;41(9):946-9.
6
Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.依普利酮:一种用于治疗高血压和心力衰竭的选择性醛固酮受体拮抗剂。
Heart Dis. 2003 Sep-Oct;5(5):354-63. doi: 10.1097/01.hdx.0000089783.30450.cb.
7
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension.螺内酯、依普利酮和新型醛固酮受体拮抗剂在内分泌性和原发性高血压中的应用。
J Hypertens. 2013 Jan;31(1):3-15. doi: 10.1097/HJH.0b013e3283599b6a.
8
Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats.新型盐皮质激素受体拮抗剂 SM-368229 在醛固酮/盐处理大鼠中的降压和心脏肾脏保护作用。
Pharmacology. 2012;89(1-2):44-52. doi: 10.1159/000335559. Epub 2012 Feb 1.
9
Pharmacokinetics and metabolism of mespirenone, a new aldosterone antagonist, in rat and cynomolgus monkey.新型醛固酮拮抗剂美螺内酯在大鼠和食蟹猴体内的药代动力学及代谢
Xenobiotica. 1987 May;17(5):623-34. doi: 10.3109/00498258709043969.
10
Eplerenone: cardiovascular protection.依普利酮:心血管保护作用。
Circulation. 2003 May 20;107(19):2512-8. doi: 10.1161/01.CIR.0000071081.35693.9A.

引用本文的文献

1
Mineralocorticoid receptor antagonists in cardiovascular translational biology.心血管转化生物学中的盐皮质激素受体拮抗剂
Cardiovasc Endocrinol Metab. 2023 Aug 21;12(3):e0289. doi: 10.1097/XCE.0000000000000289. eCollection 2023 Sep.